Enkay Pharma Consulting Ltd

Specific area of expertise is non-alcoholic fatty liver disease and NASH. Led the initiative to develop two promising compounds in this disease. Have a wide network of KOLs, arranged two expert panels, had discussions with European regulatory agencies and developed POC protocols to test the efficacy and safety of these drugs.

❖ Strong commitment to continuing education and personal development with special transferable skills in working to achieve access for healthcare to the developing world and Base of the Pyramid

❖ Experience includes extensive Phase 2 and 3 drug development and therapeutic area expertise in Sexual Health (sildenafil), Obesity, Metabolic Diseases and Gastrointestinal-Hepatology Therapeutic Areas (TA).

❖ Developed innovative initiatives and used ‘out-of-the-box’ thinking for exploration of new indications with established compounds.

❖ Strategic Clinical Plan Development, Data Analysis and Interpretation & Regulatory Agency Interaction

❖ Skilled in evaluating information from scientists, clinicians and marketers, identifying key issues and developing novel strategies to realise new opportunities. Internal & External (Key Opinion Leader [KOL]) relationship development.

❖ Strong communication skills - Fluent in written and spoken English and 4 Indian languages (Hindi, Marathi, Gujarati, Konkani); able to communicate and understand Tamil, Punjabi and Urdu as well as conversational Arabic (basic). Ability to understand, appreciate and imbibe different cultures.